KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Emergent BioSolutions (EBS) over the last 14 years, with Q3 2025 value amounting to $243.5 million.

  • Emergent BioSolutions' Treasury Shares rose 693.9% to $243.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.5 million, marking a year-over-year increase of 693.9%. This contributed to the annual value of $227.7 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Treasury Shares is $7.9 million, which was up 4107.14% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Treasury Shares ranged from a high of $7.9 million in Q3 2025 and a low of $1.2 million during Q1 2021
  • In the last 5 years, Emergent BioSolutions' Treasury Shares had a median value of $5.6 million in 2022 and averaged $5.0 million.
  • Per our database at Business Quant, Emergent BioSolutions' Treasury Shares changed by 0.0% in 2021 and then skyrocketed by 47500.0% in 2022.
  • Emergent BioSolutions' Treasury Shares (Quarter) stood at $152.2 million in 2021, then skyrocketed by 49.61% to $227.7 million in 2022, then changed by 0.0% to $227.7 million in 2023, then changed by 0.0% to $227.7 million in 2024, then grew by 6.94% to $243.5 million in 2025.
  • Its last three reported values are $243.5 million in Q3 2025, $234.6 million for Q2 2025, and $227.7 million during Q1 2025.